Literature DB >> 24027304

Involvement of the rabies virus phosphoprotein gene in neuroinvasiveness.

Satoko Yamaoka1, Naoto Ito, Seii Ohka, Shohei Kaneda, Hiroko Nakamura, Takahiro Agari, Tatsunori Masatani, Keisuke Nakagawa, Kazuma Okada, Kota Okadera, Hiromichi Mitake, Teruo Fujii, Makoto Sugiyama.   

Abstract

Rabies virus (RABV), which is transmitted via a bite wound caused by a rabid animal, infects peripheral nerves and then spreads to the central nervous system (CNS) before causing severe neurological symptoms and death in the infected individual. Despite the importance of this ability of the virus to spread from a peripheral site to the CNS (neuroinvasiveness) in the pathogenesis of rabies, little is known about the mechanism underlying the neuroinvasiveness of RABV. In this study, to obtain insights into the mechanism, we conducted comparative analysis of two fixed RABV strains, Nishigahara and the derivative strain Ni-CE, which cause lethal and asymptomatic infections, respectively, in mice after intramuscular inoculation. Examination of a series of chimeric viruses harboring the respective genes from Nishigahara in the genetic background of Ni-CE revealed that the Nishigahara phosphoprotein (P) gene plays a major role in the neuroinvasiveness by mediating infection of peripheral nerves. The results obtained from both in vivo and in vitro experiments strongly suggested that the Nishigahara P gene, but not the Ni-CE P gene, is important for stable viral replication in muscle cells. Further investigation based on the previous finding that RABV phosphoprotein counteracts the host interferon (IFN) system demonstrated that the Nishigahara P gene, but not the Ni-CE P gene, functions to suppress expression of the beta interferon (IFN-β) gene (Ifn-β) and IFN-stimulated genes in muscle cells. In conclusion, we provide the first data strongly suggesting that RABV phosphoprotein assists viral replication in muscle cells by counteracting the host IFN system and, consequently, enhances infection of peripheral nerves.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24027304      PMCID: PMC3807887          DOI: 10.1128/JVI.02132-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  An effective rabies treatment in exposed monkeys: a single dose of interferon inducer and vaccine.

Authors:  G M Baer; S A Moore; J H Shaddock; H B Levy
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

2.  Regulation of the interferon system: evidence that Vero cells have a genetic defect in interferon production.

Authors:  J M Emeny; M J Morgan
Journal:  J Gen Virol       Date:  1979-04       Impact factor: 3.891

3.  Comparative pathogenesis of rabies and rabies-like viruses. Viral infection and transit from inoculation site to the central nervous system.

Authors:  F A Murphy; S P Bauer; A K Harrison; W C Winn
Journal:  Lab Invest       Date:  1973-03       Impact factor: 5.662

4.  Experimental rabies. Studies of cellular vulnerability and pathogenesis using fluorescent antibody staining.

Authors:  R T Johnson
Journal:  J Neuropathol Exp Neurol       Date:  1965-10       Impact factor: 3.685

5.  Differences in cell-to-cell spread of pathogenic and apathogenic rabies virus in vivo and in vitro.

Authors:  B Dietzschold; T J Wiktor; J Q Trojanowski; R I Macfarlan; W H Wunner; M J Torres-Anjel; H Koprowski
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

6.  Experimental rabies in skunks: immunofluorescence light and electron microscopic studies.

Authors:  K M Charlton; G A Casey
Journal:  Lab Invest       Date:  1979-07       Impact factor: 5.662

7.  Early street rabies virus infection in striated muscle and later progression to the central nervous system.

Authors:  F A Murphy; S P Bauer
Journal:  Intervirology       Date:  1974       Impact factor: 1.763

8.  Successful prophylaxis against rabies in mice and Rhesus monkeys: the interferon system and vaccine.

Authors:  G M Baer; J H Shaddock; S A Moore; P A Yager; S S Baron; H B Levy
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

9.  Entry of rabies virus into the peripheral nerves of mice.

Authors:  H D Watson; G H Tignor; A L Smith
Journal:  J Gen Virol       Date:  1981-10       Impact factor: 3.891

10.  LRRK2 kinase inhibition prevents pathological microglial phagocytosis in response to HIV-1 Tat protein.

Authors:  Daniel F Marker; Jenna M Puccini; Taryn E Mockus; Justin Barbieri; Shao-Ming Lu; Harris A Gelbard
Journal:  J Neuroinflammation       Date:  2012-11-29       Impact factor: 8.322

View more
  23 in total

1.  Prokaryotic Expression, Purification, and Polyclonal Antibody Production of a Truncated Recombinant Rabies Virus L Protein.

Authors:  Jinyang Zhang; Zian Jin; Tao Sun; Yan Jiang; Qinqin Han; Yuzhu Song; Qiang Chen; Xueshan Xia
Journal:  Iran J Biotechnol       Date:  2015-06       Impact factor: 1.671

Review 2.  Rabies virus vaccine as an immune adjuvant against cancers and glioblastoma: new studies may resurrect a neglected potential.

Authors:  M A Altinoz; S Guloksuz; I Elmaci
Journal:  Clin Transl Oncol       Date:  2017-01-16       Impact factor: 3.405

3.  Roles of the Rabies Virus Phosphoprotein Isoforms in Pathogenesis.

Authors:  Kazuma Okada; Naoto Ito; Satoko Yamaoka; Tatsunori Masatani; Hideki Ebihara; Hideo Goto; Kento Nakagawa; Hiromichi Mitake; Kota Okadera; Makoto Sugiyama
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

Review 4.  Everything You Always Wanted to Know About Rabies Virus (But Were Afraid to Ask).

Authors:  Benjamin M Davis; Glenn F Rall; Matthias J Schnell
Journal:  Annu Rev Virol       Date:  2015-06-24       Impact factor: 10.431

5.  Molecular Function Analysis of Rabies Virus RNA Polymerase L Protein by Using an L Gene-Deficient Virus.

Authors:  Kento Nakagawa; Yuki Kobayashi; Naoto Ito; Yoshiyuki Suzuki; Kazuma Okada; Machiko Makino; Hideo Goto; Tatsuki Takahashi; Makoto Sugiyama
Journal:  J Virol       Date:  2017-09-27       Impact factor: 5.103

6.  An unprecedented cluster of Australian bat lyssavirus in Pteropus conspicillatus indicates pre-flight flying fox pups are at risk of mass infection.

Authors:  Janine Barrett; Alison Höger; Kalpana Agnihotri; Jane Oakey; Lee F Skerratt; Hume E Field; Joanne Meers; Craig Smith
Journal:  Zoonoses Public Health       Date:  2020-04-20       Impact factor: 2.702

Review 7.  The spread and evolution of rabies virus: conquering new frontiers.

Authors:  Christine R Fisher; Daniel G Streicker; Matthias J Schnell
Journal:  Nat Rev Microbiol       Date:  2018-02-26       Impact factor: 60.633

Review 8.  Lyssaviruses and bats: emergence and zoonotic threat.

Authors:  Ashley C Banyard; Jennifer S Evans; Ting Rong Luo; Anthony R Fooks
Journal:  Viruses       Date:  2014-08-04       Impact factor: 5.048

Review 9.  The importance of immune evasion in the pathogenesis of rabies virus.

Authors:  Naoto Ito; Gregory W Moseley; Makoto Sugiyama
Journal:  J Vet Med Sci       Date:  2016-04-02       Impact factor: 1.267

Review 10.  Subversion of the Immune Response by Rabies Virus.

Authors:  Terence P Scott; Louis H Nel
Journal:  Viruses       Date:  2016-08-19       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.